Posiflex to Showcase Industry-first Clamshell Design POS at EuroShop 2023—Aims to Redefine Business Efficiency
Ranked as one of the top 5 POS brands worldwide, Posiflex Technology Inc. has a unique position with its strong design expertise, manufacturing capabilities and delivery of POS Terminal and peripherals, offering one-stop-shop service to best fit customers’ requirements. Moving toward a further leap in its global-leading position, Posiflex will take the stage at EuroShop Düsseldorf 2023 to showcase the latest innovations in upcoming POS Terminal technology and Kiosk solutions, along with a live demo experience with retail and hospitality applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230223005501/en/
Posiflex Technology, Inc. will attend EuroShop 2023 at Hall 6 / C42, in Düsseldorf, Germany. (Photo: Business Wire)
Innovations Exploring Retail POSsibilities
As the industry‘s first POS Terminal with a clamshell design, the Haydn ZT Series has a display housing that can be easily opened and closed with a one-touch button. The “hood-like” design offers an unprecedentedly convenient and efficient maintenance experience. With the Haydn ZT Series, speed of maintenance can be four times faster when compared to maintenance with the conventional terminal design.
The clamshell design has also inspired and enabled the screw-less and modular component design under the hood— the motherboard, display and RAM module are all removable without removing any screws. The screw-less maintenance greatly reduces downtime and minimizes customer frustration. Haydn ZT Series stands out also with innovative features focusing on applications, including hidden I/O ports, a hidden power adapter, three-way cable management, together with a new all-in-one design of a Gen 9 POS base which creatively integrates a receipt printer inside the POS base to maintain ultra-clean and space-economic aesthetics and to complement the terminal that maximizes speed, efficiency and productivity.
Application-specific Kiosks Redefining Business Operations
Posiflex will also unveil an array of new kiosk products, which will fully demonstrate self-service technologies with flexible deployment options including stand-alone, wall-mounted or countertop configurations to realize how kiosks benefit omnichannel retail for various applications such as online orders with physical deliverables.
The live demos at Posiflex’s booth will illustrate user scenarios including a dual-sided kiosk, which allows two users at once, a perfect solution for space-limited environments. Moreover, as international tourism is on the rise, a hotel check-in kiosk to demonstrate a fast, safe and effective self-check-in and check-out process that can increase efficiency.
“Our booth at EuroShop 2023 showcases how the innovations we have put into our products are tailored for users’ convenience and elevates merchants’ overall success in business,” said Owen Chen, CEO of Posiflex Technology Inc.
Visit our booth at Hall 6/C42 from Feb. 26th to Mar. 2nd, 2023 to see how Posiflex can benefit your business with innovative technologies and products.
About POSIFLEX Group
Posiflex Group is a global leading Commercial Internet of Things (CIoT) enabler dedicated to providing O2O and embedded solutions. The group now is pillared by three business entities—Posiflex Technology, Portwell Inc. and US-based KIOSK Information Systems (KIS), specialized in the manufacturing of POS, embedded IPC and self-service kiosk respectively, with a common goal in pursuing a brave new world of smart commerce, where transactions become faster and more convenient physically or digitally.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223005501/en/
Contact information
Posiflex Marekting Division: Jessiehsu@posiflex.com.tw
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit28.4.2024 14:57:00 EEST | Press release
TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/ TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire) Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom